Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
XTLB
$1.19
+1.71%
Analyze
1M
+1.7%
3M
-32.0%
1Y
-39.9%
Market Cap:
$10.49M
XTL Biopharmaceuticals Ltd ADR
Healthcare |
Biotechnology
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, is engaged in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company is headquartered in Ramat Gan, Israel.
Click "Analyze" to generate stock analysis
XTLB Price Trend and Signals
XTLB Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-17
Somewhat Bearish
macd_signal
Dead cross above zero detected.
2025-10-09
Bearish
price_signal
Large price change detected: -20.49%.